A novel wireless photothermal DBS nanosystem uses nanoparticles to target and restore damaged neurons in…
Browsing: Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that primarily affects movement, caused by the degeneration of dopamine-producing neurons in a region of the brain called the substantia nigra. Common symptoms include tremors, muscle rigidity, slowness of movement, and balance difficulties, though it can also lead to cognitive and mood changes over time. While the exact cause remains unclear, research points to a combination of genetic and environmental factors. Ongoing studies are focused on understanding the molecular mechanisms behind the disease, developing better treatments, and exploring potential avenues for neuroprotection and regeneration.
Lancaster University research found that hearing loss may increase the risk of Parkinson’s disease by…
A new study has identified polyphosphate as a likely “mystery density” within fibrils associated with…
University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in…
Mount Sinai researchers have improved an AI tool for diagnosing a major sleep disorder from…
Researchers at the Champalimaud Foundation have uncovered new insights into the complex link between dopamine…
A study from the University of Arizona shows that the protein PNA5 helps protect brain…
Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking G4s with…
Model mice treated with extracts and powders exhibit restored cognitive and motor functions. Efforts to…
A new study suggests multiple penicillin courses may lower Parkinson’s risk by impacting gut bacteria,…
A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new…
Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using magnetic…
Researchers have developed a method to recreate the formation of Lewy bodies in human neurons,…
Scientists researched a drug called IU1 for its potential to alleviate age-related issues in protein…
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader…
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia,…
Scientists discovered a link between copper regulation and neurodegeneration, using the worm gene swip-10. Their…
Research enhances our comprehension of neurodegenerative diseases associated with protein aggregation. A recent study published…